相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the gut-liver-immune axis to treat cirrhosis
Thomas Henry Tranah et al.
GUT (2021)
Hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
Activating killer cell immunoglobulin-like receptors: Detection, function and therapeutic use
Matthew D. Blunt et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2020)
Comprehensive characterization of tumor infiltrating natural killer cells and clinical significance in hepatocellular carcinoma based on gene expression profiles
Mei Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
MAITCells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis
Christian E. Niehaus et al.
HEPATOLOGY (2020)
CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors
Haiping Wang et al.
NATURE IMMUNOLOGY (2020)
Tuning of human NK cells by endogenous HLA-C expression
Frederick J. Goodson-Gregg et al.
IMMUNOGENETICS (2020)
Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival
SiZhe Yu et al.
PLOS ONE (2020)
ULBP1 Is Elevated in Human Hepatocellular Carcinoma and Predicts Outcome
Nicholas J. W. Easom et al.
FRONTIERS IN ONCOLOGY (2020)
The hepatic microenvironment and regulatory T cells
Daniel Osei-Bordom et al.
CELLULAR IMMUNOLOGY (2020)
Clonal expansion of innate and adaptive lymphocytes
Nicholas M. Adams et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
Roser Pinyol et al.
GUT (2019)
Deficient Natural Killer Cell NKp30-Mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
Stefania Mantovani et al.
HEPATOLOGY (2019)
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
Jodie P. Goodridge et al.
NATURE COMMUNICATIONS (2019)
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
Yoshihiro Ohue et al.
CANCER SCIENCE (2019)
A Positive Feedback Loop Between Cancer Stem-Like Cells and Tumor-Associated Neutrophils Controls Hepatocellular Carcinoma Progression
Shao-Lai Zhou et al.
HEPATOLOGY (2019)
Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells
Takahiro Kamiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Results of KEYNOTE-240: phase 3 study of pembrolizumab (Pembro) vs best supportive care (BSC) for second line therapy in advanced hepatocellular carcinoma (HCC).
Richard S. Finn et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Accumulation of Tumor-Infiltrating CD49a+ NK Cells Correlates with Poor Prognosis for Human Hepatocellular Carcinoma
Haoyu Sun et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
Francesca Maria Consonni et al.
FRONTIERS IN IMMUNOLOGY (2019)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende et al.
FRONTIERS IN IMMUNOLOGY (2019)
Cytotoxic effects of ex vivo-expanded natural killer cell-enriched lymphocytes (MYJ1633) against liver cancer
Jung-Won Choi et al.
BMC CANCER (2019)
A Phase I Study of the Anti-CC Chemokine Receptor 4 Antibody, Mogamulizumab, in Combination with Nivolumab in Patients with Advanced or Metastatic Solid Tumors
Toshihiko Doi et al.
CLINICAL CANCER RESEARCH (2019)
Mass Production of Highly Active NK Cells for Cancer Immunotherapy in a GMP Conform Perfusion Bioreactor
Katharine Broeker et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
LBA38_PRCheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC)
T Yau et al.
ANNALS OF ONCOLOGY (2019)
Role of regulatory T cells and checkpoint inhibition in hepatocellular carcinoma
Bettina Langhans et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)
Somatic mutations and clonal dynamics in healthy and cirrhotic human liver
Simon F. Brunner et al.
NATURE (2019)
Impairment of NKG2D-Mediated Tumor Immunity by TGF-β
Mariya Lazarova et al.
FRONTIERS IN IMMUNOLOGY (2019)
Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
Jun Wang et al.
CELL (2019)
Human CD96 Correlates to Natural Killer Cell Exhaustion and Predicts the Prognosis of Human Hepatocellular Carcinoma
Haoyu Sun et al.
HEPATOLOGY (2019)
CD4+ CD25+ regulatory T cells promote hepatocellular carcinoma invasion via TGF-β1-induced epithelial-mesenchymal transition
Chunying Shi et al.
ONCOTARGETS AND THERAPY (2019)
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemia
Sarah Cooley et al.
BLOOD ADVANCES (2019)
Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
Katharine Margaret Irvine et al.
FRONTIERS IN IMMUNOLOGY (2019)
Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity
Ye Li et al.
CELL STEM CELL (2018)
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
Andreas T. Bjorklund et al.
CLINICAL CANCER RESEARCH (2018)
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
Andrew X. Zhu et al.
LANCET ONCOLOGY (2018)
Hepatotoxicity of immune checkpoint inhibitors: a histology study of seven cases in comparison with autoimmune hepatitis and idiosyncratic drug-induced liver injury
Yoh Zen et al.
MODERN PATHOLOGY (2018)
Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity
Qing Zhang et al.
NATURE IMMUNOLOGY (2018)
Molecular therapies and precision medicine for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
The Paradoxical Role of NKG2D in Cancer Immunity
Sam Sheppard et al.
FRONTIERS IN IMMUNOLOGY (2018)
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
Pascale Andre et al.
CELL (2018)
Association Between Expression Level of PD1 by Tumor-Infiltrating CD8+ T Cells and Features of Hepatocellular Carcinoma
Hyung-Don Kim et al.
GASTROENTEROLOGY (2018)
Changes in Natural Killer Cells and Exhausted Memory Regulatory T Cells With Corticosteroid Therapy in Acute Autoimmune Hepatitis
Hannah C. Jeffery et al.
HEPATOLOGY COMMUNICATIONS (2018)
Human natural killer cells and other innate lymphoid cells in cancer: Friends or foes?
Paola Vacca et al.
IMMUNOLOGY LETTERS (2018)
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
Anthony B. El-Khoueiry et al.
LANCET (2017)
Lectin-complement pathway molecules are decreased in patients with cirrhosis and constitute the risk of bacterial infections
Ildiko Foldi et al.
LIVER INTERNATIONAL (2017)
Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value
Yong-Ting Lan et al.
MEDICINE (2017)
Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet
P. E. Bunney et al.
PHYSIOLOGY & BEHAVIOR (2017)
Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses
Valerie Chew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The immunoreceptor NKG2D promotes tumour growth in a model of hepatocellular carcinoma
Sam Sheppard et al.
NATURE COMMUNICATIONS (2017)
Th17/Treg imbalance is an indicator of liver cirrhosis process and a risk factor for HCC occurrence in HBV patients
Kun Li et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
PD-L1, Galectin-9 and CD8+ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma
Kostandinos Sideras et al.
ONCOIMMUNOLOGY (2017)
Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score
Hannah C. Jeffery et al.
PLOS ONE (2017)
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
Marianne Forkel et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases
H. C. Jeffery et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)
Liver natural killer cells: subsets and roles in liver immunity
Hui Peng et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients
Yaxian Kong et al.
CLINICAL CANCER RESEARCH (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Human Intrahepatic Regulatory T Cells Are Functional, Require IL-2 From Effector Cells for Survival, and Are Susceptible to Fas Ligand-Mediated Apoptosis
Yung-Yi Chen et al.
HEPATOLOGY (2016)
Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features
Julien Calderaro et al.
HEPATOLOGY (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
Rizwan Romee et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Regulatory T cells, especially ICOS+ FOXP3+ regulatory T cells, are increased in the hepatocellular carcinoma microenvironment and predict reduced survival
Jian-Fei Tu et al.
SCIENTIFIC REPORTS (2016)
Natural killer cells phenotypic characterization as an outcome predictor of HCV-linked HCC after curative treatments
Elisabetta Cariani et al.
ONCOIMMUNOLOGY (2016)
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun et al.
ACTA PHARMACOLOGICA SINICA (2015)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Hepatic Inflammation and Fibrosis: Functional Links and Key Pathways
Ekihiro Seki et al.
HEPATOLOGY (2015)
TIGIT and PD-1 impair tumor antigen-specific CD8+ T cells in melanoma patients
Joe-Marc Chauvin et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
TIGIT predominantly regulates the immune response via regulatory T cells
Sema Kurtulus et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immunological landscape and immunotherapy of hepatocellular carcinoma
Jesus Prieto et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection
Elisabeth Littwitz-Salomon et al.
RETROVIROLOGY (2015)
PD-1-PD-L1 axis: efficient checkpoint blockade against cancer
Alessia Errico
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
Trained Immunity or Tolerance: Opposing Functional Programs Induced in Human Monocytes after Engagement of Various Pattern Recognition Receptors
Daniela C. Ifrim et al.
CLINICAL AND VACCINE IMMUNOLOGY (2014)
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
Lidia Robert et al.
CLINICAL CANCER RESEARCH (2014)
Treg Cells Expressing the Coinhibitory Molecule TIGIT Selectively Inhibit Proinflammatory Th1 and Th17 Cell Responses
Nicole Joller et al.
IMMUNITY (2014)
Regulatory T cells and autoimmune hepatitis: What happens in the liver stays in the liver
Ye H. Oo et al.
JOURNAL OF HEPATOLOGY (2014)
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
Agustin Albillos et al.
JOURNAL OF HEPATOLOGY (2014)
NK Cells with KIR2DS2 Immunogenotype Have a Functional Activation Advantage To Efficiently Kill Glioblastoma and Prolong Animal Survival
Andrea Gras Navarro et al.
JOURNAL OF IMMUNOLOGY (2014)
CD56brightPerforinlow Noncytotoxic Human NK Cells Are Abundant in Both Healthy and Neoplastic Solid Tissues and Recirculate to Secondary Lymphoid Organs via Afferent Lymph
Paolo Carrega et al.
JOURNAL OF IMMUNOLOGY (2014)
Alterations of the human gut microbiome in liver cirrhosis
Nan Qin et al.
NATURE (2014)
The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota
Maria L. Balmer et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Higher Frequencies of GARP+CTLA-4+Foxp3+ T Regulatory Cells and Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma Patients Are Associated with Impaired T-Cell Functionality
Suresh Kalathil et al.
CANCER RESEARCH (2013)
Recruitment of Grb2 and SHIP1 by the ITT-like motif of TIGIT suppresses granule polarization and cytotoxicity of NK cells
S. Liu et al.
CELL DEATH AND DIFFERENTIATION (2013)
HLA and Killer Immunoglobulin-like Receptor Genes as Outcome Predictors of Hepatitis C Virus-Related Hepatocellular Carcinoma
Elisabetta Cariani et al.
CLINICAL CANCER RESEARCH (2013)
Immunomodulatory therapy for melanoma: Ipilimumab and beyond
Margaret K. Callahan et al.
CLINICS IN DERMATOLOGY (2013)
Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions
Yan Wu et al.
HEPATOLOGY (2013)
Natural killer cells in liver disease
Zhigang Tian et al.
HEPATOLOGY (2013)
Defective thymopoiesis and poor peripheral homeostatic replenishment of T-helper cells cause T-cell lymphopenia in cirrhosis
Margaret Lario et al.
JOURNAL OF HEPATOLOGY (2013)
Intrahepatic IL-8 producing Foxp3+CD4+ regulatory T cells and fibrogenesis in chronic hepatitis C
Bettina Langhans et al.
JOURNAL OF HEPATOLOGY (2013)
At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
Andrew M. Intlekofer et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production
Stefania Laurent et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Markus Kleinewietfeld et al.
SEMINARS IN IMMUNOLOGY (2013)
Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products
Robert Skeate et al.
TRANSFUSION (2013)
High immunosuppressive burden in advanced hepatocellular carcinoma patients Can effector functions be restored?
Amit A. Lugade et al.
ONCOIMMUNOLOGY (2013)
Clinical grade purification and expansion of NK cell products for an optimized manufacturing protocol
Ulrike Koehl et al.
FRONTIERS IN ONCOLOGY (2013)
Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas
Jie Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma
Valerie Chew et al.
GUT (2012)
Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-Positive B-cell population
Hiroyoshi Doi et al.
HEPATOLOGY (2012)
Vstm3 is a member of the CD28 family and an important modulator of T-cell function
Steven D. Levin et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
PD-1 and PD-L1 upregulation promotes CD8+ T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients
Feng Shi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Up-regulated myeloid-derived suppressor cell contributes to hepatocellular carcinoma development by impairing dendritic cell function
Cheng-En Hu et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
Don M. Benson et al.
BLOOD (2010)
Th17 and Regulatory T Cells in Mediating and Restraining Inflammation
Dan R. Littman et al.
CELL (2010)
Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C
Bettina Langhans et al.
CLINICAL SCIENCE (2010)
The Role of Chemokines in the Recruitment of Lymphocytes to the Liver
Ye H. Oo et al.
DIGESTIVE DISEASES (2010)
Sorafenib Inhibits the Shedding of Major Histocompatibility Complex Class I-Related Chain A on Hepatocellular Carcinoma Cells by Down-Regulating a Disintegrin and Metalloproteinase 9
Keisuke Kohga et al.
HEPATOLOGY (2010)
Expansion of CD4+CD25+FoxP3+regulatory T cells in hepatitis C virus-related chronic hepatitis, cirrhosis and hepatocellular carcinoma
Kai Yoshizawa et al.
HEPATOLOGY RESEARCH (2010)
Distinct Roles for CCR4 and CXCR3 in the Recruitment and Positioning of Regulatory T Cells in the Inflamed Human Liver
Ye H. Oo et al.
JOURNAL OF IMMUNOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia
Sarah Cooley et al.
BLOOD (2009)
Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy
Hiroyuki Fujisaki et al.
CANCER RESEARCH (2009)
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma
Thomas Amann et al.
CANCER SCIENCE (2009)
Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
Qiang Gao et al.
CLINICAL CANCER RESEARCH (2009)
A novel molecular interaction for the adhesion of follicular CD4 T cells to follicular DC
Kent S. Boles et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Targeting Transforming Growth Factor (TGF)-βRI Inhibits Activation of β1 Integrin and Blocks Vascular Invasion in Hepatocellular Carcinoma
Emilia Fransvea et al.
HEPATOLOGY (2009)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
Feng Wang et al.
IMMUNOBIOLOGY (2009)
Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients
Jia Zhou et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells
Xin Yu et al.
NATURE IMMUNOLOGY (2009)
The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity
Noa Stanietsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Immunomodulatory drugs Revlimid (R) (lenalidomide) and CC-4047 induce apoptosis of both hematological and solid tumor cells through NK cell activation
Dan Zhu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients
Lun Cai et al.
CLINICAL IMMUNOLOGY (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Transforming growth factor-β gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer
Cedric Coulouarn et al.
HEPATOLOGY (2008)
Accelerated tumor growth in mice deficient in DNAM-1 receptor
Akiko Iguchi-Manaka et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
DNAM-1 promotes activation of cytotoxic lymphocytes by nonprofessional antigen-presenting cells and tumors
Susan Gilfillan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression
Francois Ghiringhelli et al.
IMMUNOLOGICAL REVIEWS (2006)
Antitumoral activity of interferon-γ involved in impaired immune function in cancer patients
Gerald Brandacher et al.
CURRENT DRUG METABOLISM (2006)
Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment
Anuradha Budhu et al.
CANCER CELL (2006)
Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation
Esther Unitt et al.
JOURNAL OF HEPATOLOGY (2006)
CTLA-4 overexpression inhibits T cell responses through a CD28-B7-dependent mechanism
John J. Engelhardt et al.
JOURNAL OF IMMUNOLOGY (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells
JS Lee et al.
NATURE MEDICINE (2006)
The liver as an immunological organ
V Racanelli et al.
HEPATOLOGY (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
CD4+ CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Inhibition of NK cell activity through TGF-β1 by down-regulation of NKG2D in a murine model of head and neck cancer
S Dasgupta et al.
JOURNAL OF IMMUNOLOGY (2005)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection
A López-Vázquez et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
M Kisielow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma
LA Ormandy et al.
CANCER RESEARCH (2005)
Molecular mechanisms whereby immunomodulatory drugs activate natural killer cells: clinical application
T Hayashi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
TGF-β1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice
K Nakamura et al.
JOURNAL OF IMMUNOLOGY (2004)
The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity
DG Bowen et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Stromal fibroblasts in cancer initiation and progression
NA Bhowmick et al.
NATURE (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
MHC class II signal transduction in human dendritic cells induced by a natural ligand, the LAG-3 protein (CD223)
S Andreae et al.
BLOOD (2003)
Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning
QH Ye et al.
NATURE MEDICINE (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Killer Ig-like receptor haplotype analysis by gene content: Evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets
KC Hsu et al.
JOURNAL OF IMMUNOLOGY (2002)
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
L Ruggeri et al.
SCIENCE (2002)
The enemy within: Keeping self-reactive T cells at bay in the periphery
LSK Walker et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma
FE Davies et al.
BLOOD (2001)
In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease
C Fiuza et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
分享论文
